Form 6-K POMDOCTOR Ltd For: Jul 15

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

For the month of July 2026

 

Commission file number: 001-42749

 

 

POMDOCTOR LIMITED

 

 

Yongxu Industrial Park
No.19-23 Hejing Road, Dongsha Street
Liwan District, Guangzhou 510000

People’s Republic of China

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒    Form 40-F ☐

 

 

 

EXHIBIT INDEX

 

Exhibit No.		Description
99.1		Press Release—POMDOCTOR LIMITED Advances Healthcare Data Asset Strategy to Strengthen AI-Powered Chronic Disease Management Capabilities

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	POMDOCTOR LIMITED
	/s/ Zhenyang Shi
	Zhenyang Shi
	Chairman and Chief Executive Officer

 

Date: July 15, 2026

 

 

2

 

ATTACHMENTS / EXHIBITS

PRESS RELEASE-POMDOCTOR LIMITED ADVANCES HEALTHCARE DATA ASSET STRATEGY TO STRENGTHEN AI-POWERED CHRONIC DISEASE MANAGEMENT CAPABILITIES

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Alstom S.A.: Alstom and its partners reach financial close for Israel’s Haifa-Nazareth light rail project
• Tensive reports pivotal 12-month clinical trial data confirming REGENERA™ delivers natural breast reconstruction after lumpectomy
• USHIO Industry & Entertainment Announces Trademark Licensing Agreement for OSRAM-Branded Professional Technical Lighting Products